+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CymaBay Therapeutics - logo
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • March 2024
  • 500 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH) - Product Thumbnail Image

Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)

  • Report
  • November 2018
  • 52 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 83 Pages
  • Global
From
Hypercholesterolemia Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hypercholesterolemia Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 82 Pages
  • Global
From
Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H1 20 - Product Thumbnail Image

Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H1 20

  • Drug Pipelines
  • June 2018
  • 31 Pages
  • Global
From
Comprehensive Report on CymaBay Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on CymaBay Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Cymabay Therapeutics Inc (CBAY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Cymabay Therapeutics Inc (CBAY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2020
  • 82 Pages
From
CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2023
  • 48 Pages
From
  • 9 Results (Page 1 of 1)
Loading Indicator